Koga H, Zhang S, Washiyama K, Ichikawa T, Onda K, Kumanishi T
Department of Neuropathology, Niigata, University.
Noshuyo Byori. 1996 Apr;13(1):1-10.
Seven human glioma cell lines were examined for mutations of the p53 gene and their mRNA and protein expressions. Five cell lines revealed a missense mutation at, codons 237, 245, or 273. Their p53 mRNA expression was variably distinct and not always comparable to p53 protein expression, suggesting difference in the transcriptional and posttranscriptional regulation. One cell line had a splicing mutation in intron 9 and abnormal splicing was actually demonstrated by RT-PCR analysis. The remaining 1 cell line showed no PCR-amplification of the p53 gene sequence. In an examination of the original tumor tissues, the same mutations were demonstrated in the 5 tumors examined, strongly suggesting that the mutations in the glioma cell lines were derived from their original tumor tissues.
对七种人类胶质瘤细胞系进行了p53基因的突变及其mRNA和蛋白质表达检测。五个细胞系在密码子237、245或273处出现错义突变。它们的p53 mRNA表达各不相同,且并不总是与p53蛋白表达具有可比性,这表明转录和转录后调控存在差异。一个细胞系在内含子9中存在剪接突变,RT-PCR分析实际证实了异常剪接。其余1个细胞系未显示p53基因序列的PCR扩增。在对原始肿瘤组织的检测中,在所检测的5个肿瘤中证实了相同的突变,这强烈表明胶质瘤细胞系中的突变源自其原始肿瘤组织。